Satsuma Pharmaceuticals Inc. (STSA) Income Statement

Click line-items for a historical chart and %

Loans	87.19M
MBS	8.31M
Investments and cash equivalents
Total interest income	97.8M
Deposits	5.48M
Short-term borrowings	238K
Long-term borrowings	7.71M
Total interest expense	13.43M
Net interest income	84.38M
Provision for credit losses	0
Net interest income (expense) after provision for credit losses	84.38M
Fees and service charges	15.79M
Mortgage banking operations	9.49M
Loan servicing fees
BOLI	1.61M
Gains on sales of securities, net	0
Other
Total noninterest income	29.13M
Noninterest expense	84.37M
Income (loss) before income taxes	29.13M
Income tax expense	-6.98M
Net income (loss)
Preferred stock dividend
Net income (loss) available to common shareholders
Earnings (loss) per share - basic	0.35
Earnings (loss) per share - diluted	0.35
Weighted average shares outstanding - basic	-124.55M
Weighted average shares outstanding - diluted	-126.2M

Entities mentioned with STSA

View All Entities